- Title: President and CEO, Trividia Health
- Industry: Healthcare
Scott Verner is Chairman, CEO and President of TRIVIDIA Health, a leading developer and manufacturer of diabetes management solutions and blood glucose monitoring systems, formed in the merger of Nipro Diagnostics Inc. and assets of Sinocare, Inc.. Before TRIVIDIA Health, Scott served as Chairman , President, and Group CEO of Nipro Diagnostics, Inc. and Chairman of two other affiliated businesses (Nipro Health Care and Applied Sciences Corporation).
Over the last 10 years, Scott has built shareholder value and created equity events for three public companies in the global consumer healthcare, medical device, and pharmaceutical industries. He possesses strong financial acumen, expertise in fund raising and restructuring debt, and operations experience with public companies, private equity, venture capital, and IPOs. Scott has an extensive record of achievement growing companies and brands, leading turnarounds, building world class sales and marketing capabilities, launching new products, and restructuring sales and marketing operations.
Throughout his tenure with TRIVIDIA Health and Nipro Diagnostics, Inc., Scott has developed strategies and driven implementation for multimillion dollar R&D investments, and championed innovation for highly automated electrical instrument, chemical, and pharmaceutical/nutrition manufacturing plants to achieve measurable gains in product quality and cost effectiveness.
In 2014, Scott was honored with a 2-year appointment to the Council of Economic Advisers for the U.S. Federal Reserve. He was named a “Power Leader in Health Care” every year since 2013 by the South Florida Business Journal, and earned the “Ultimate CEO Award” in the same year. With a bachelor’s degree from the University of Tampa, Scott resides in Parkland, Florida with his wife and two children.